Agonist-specific differences in mechanisms mediating eNOS-dependent pial arteriolar dilation in rats

Area of Science:

• Neuroscience
• Cardiovascular Physiology
• Molecular Biology

Background:

• Nitric oxide (NO), produced by endothelial NO synthase (eNOS), is crucial for dilating cerebral blood vessels.
• Understanding the signaling pathways mediating eNOS activation by different agonists is key to comprehending cerebral blood flow regulation.

Purpose of the Study:

• To investigate whether the signaling mechanisms for agonist-induced eNOS activation differ based on the stimulated receptor.
• To determine the involvement of heat shock protein 90 (HSP90), phosphatidylinositol-3-kinase (PI3K), and tyrosine kinase in acetylcholine (ACh) versus adenosine diphosphate (ADP) induced eNOS activation in rat cerebral arterioles.

Main Methods:

• Cerebral arteriolar diameter changes were measured in anesthetized rats.
• Responses to sequential applications of ACh and ADP were assessed in the presence of specific inhibitors: N(omega)-nitro-L-arginine methyl ester (L-NAME), ARR-17477, 17-(allylamino)-17-demethoxygeldanamycin (AAG), wortmannin (Wort), and tyrphostin 47 (T-47).

Main Results:

• NOS inhibition with L-NAME significantly reduced both ACh and ADP responses, confirming eNOS as the source of NO.
• Inhibition of HSP90, PI3K, and tyrosine kinase pathways (using AAG, Wort, and T-47) markedly reduced ACh-induced vasodilation.
• These same inhibitors did not alter the vasodilatory responses to ADP, indicating distinct signaling cascades.

Conclusions:

• Muscarinic receptor-mediated eNOS activation by ACh in cerebral arterioles relies on HSP90, PI3K, and tyrosine kinase signaling.
• Purinergic receptor-mediated eNOS activation by ADP involves different, yet unidentified, signal transduction pathways.
• These findings highlight distinct molecular mechanisms underlying receptor-specific eNOS activation in regulating cerebral blood flow.